A detailed history of 25 LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, 25 LLC holds 259 shares of LLY stock, worth $205,682. This represents 0.1% of its overall portfolio holdings.

Number of Shares
259
Previous 251 3.19%
Holding current value
$205,682
Previous $227 Million 0.97%
% of portfolio
0.1%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $6,177 - $7,680
8 Added 3.19%
259 $229 Million
Q2 2024

Jul 05, 2024

BUY
$724.87 - $909.04 $181,942 - $228,169
251 New
251 $227 Million
Q2 2023

Jul 19, 2023

BUY
$350.74 - $468.98 $1,052 - $1,406
3 Added 60.0%
8 $3.48 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $1,553 - $1,824
5 New
5 $2.16 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track 25 LLC Portfolio

Follow 25 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 25 LLC, based on Form 13F filings with the SEC.

News

Stay updated on 25 LLC with notifications on news.